Integration of Cell-Penetrating Peptides, Amyloidogenic Fragments, and Amino Acid Residue Modifications

Sergey V. Kravchenko,Pavel A. Domnin,Sergei Y. Grishin,Alena P. Zakhareva,Anastasiia A. Zakharova,Leila G. Mustaeva,Elena Y. Gorbunova,Margarita I. Kobyakova,Alexey K. Surin,Darya V. Poshvina,Roman S. Fadeev,Viacheslav N. Azev,Olga S. Ostroumova,Svetlana A. Ermolaeva,Oxana V. Galzitskaya

DOI: https://doi.org/10.3390/ijms25116030

IF: 5.6

2024-05-31

International Journal of Molecular Sciences

Abstract:The escalating threat of multidrug-resistant pathogens necessitates innovative approaches to combat infectious diseases. In this study, we examined peptides R23FS*, V31KS*, and R44KS*, which were engineered to include an amyloidogenic fragment sourced from the S1 protein of S. aureus, along with one or two cell-penetrating peptide (CPP) components. We assessed the antimicrobial efficacy of these peptides in a liquid medium against various strains of both Gram-positive bacteria, including S. aureus (209P and 129B strains), MRSA (SA 180 and ATCC 43300 strains), and B. cereus (strain IP 5832), and Gram-negative bacteria such as P. aeruginosa (ATCC 28753 and 2943 strains) and E. coli (MG1655 and K12 strains). Peptides R23FS*, V31KS*, and R44KS* exhibited antimicrobial activity comparable to gentamicin and meropenem against all tested bacteria at concentrations ranging from 24 to 48 μM. The peptides showed a stronger antimicrobial effect against B. cereus. Notably, peptide R44KS* displayed high efficacy compared to peptides R23FS* and V31KS*, particularly evident at lower concentrations, resulting in significant inhibition of bacterial growth. Furthermore, modified peptides V31KS* and R44KS* demonstrated enhanced inhibitory effects on bacterial growth across different strains compared to their unmodified counterparts V31KS and R44KS. These results highlight the potential of integrating cell-penetrating peptides, amyloidogenic fragments, and amino acid residue modifications to advance the innovation in the field of antimicrobial peptides, thereby increasing their effectiveness against a broad spectrum of pathogens.

biochemistry & molecular biology,chemistry, multidisciplinary

What problem does this paper attempt to address?

The paper aims to address the increasingly serious threat posed by multidrug-resistant pathogens by developing novel antimicrobial peptides (AMPs) to combat infectious diseases. The research team designed a series of antimicrobial peptides that include cell-penetrating peptides (CPPs), amyloidogenic fragments, and amino acid modifications, with the goal of enhancing the effectiveness and specificity of these peptides against various pathogens.

Specifically, the researchers constructed three peptides: R23FS*, V31KS*, and R44KS*. These peptides contain amyloidogenic fragments from the ribosomal protein S1 of Staphylococcus aureus (S. aureus) and include one or two CPP components (such as TAT or Antp fragments). These peptides underwent amino acid modifications, including amidation at the C-terminus of the peptide chain and the substitution of certain standard amino acid residues with other standard or non-standard amino acids.

The study evaluated the antimicrobial activity of these peptides in liquid media against various Gram-positive bacteria (including different strains of S. aureus, methicillin-resistant S. aureus MRSA, and Bacillus cereus B. cereus) and Gram-negative bacteria (including Pseudomonas aeruginosa P. aeruginosa and Escherichia coli E. coli). The results were compared with traditional antibiotics gentamicin and meropenem. The findings showed that these peptides exhibited antimicrobial effects comparable to gentamicin at concentrations of 24 to 48 μM, with the strongest activity observed against B. cereus. Among them, the R44KS* peptide demonstrated significant antimicrobial effects at lower concentrations, outperforming the other two peptides.

Additionally, the study tested the cytotoxicity of these peptides on human fibroblasts and lung cancer cells, as well as their impact on lipid bilayer ion permeability. The results indicated that while some peptides exhibited certain cytotoxicity at higher concentrations, overall, these peptides had good biocompatibility and could affect bacterial membrane permeability, which might be one of their antimicrobial mechanisms.

In summary, this study successfully enhanced the effectiveness and specificity of antimicrobial peptides by integrating CPPs, amyloidogenic fragments, and amino acid modifications, providing new insights for the development of novel antimicrobial agents.